Tag: pioneering treatment

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) has for the first time approved a product used in a specific type of therapy for blood-related cancers (hematological), such as leukemia, lymphoma and myeloma. The product is designed...